» Articles » PMID: 21696910

The Prevalence of Endocrinopathic Laminitis Among Horses Presented for Laminitis at a First-opinion/referral Equine Hospital

Overview
Publisher Elsevier
Date 2011 Jun 24
PMID 21696910
Citations 38
Authors
Affiliations
Soon will be listed here.
Abstract

Endocrinopathic causes of laminitis may be a common underlying causative pathogenesis in first-opinion or field cases presenting with laminitis, as opposed to laminitis produced in inflammatory research models. This study aimed to determine whether evidence of an underlying endocrinopathy was present in horses presented for laminitis to a first-opinion/referral veterinary teaching hospital. A second aim was to compare the signalment of horses and ponies with laminitis with the equine hospital population during the same period. All horses presenting for laminitis at Helsinki University Equine Teaching Hospital, Finland, over a 16-month period were examined for an underlying endocrinopathy. Horses presenting for laminitis were compared with the hospitalized population over the same period. There were 36 horses presented for laminitis, and evidence of endocrinopathy was present in 89%. Of the horses showing an underlying endocrinopathy, one-third had a diagnosis of pituitary pars intermedia dysfunction, and two-thirds showed basal hyperinsulinemia indicative of insulin resistance, without evidence of hirsutism. Phenotypic indicators of obesity were present in 95% of horses with basal hyperinsulinemia without hirsutism. Compared with the hospital population during the same period, horses with laminitis associated with an underlying endocrinopathy were significantly older and more likely to be pony breeds. Our data support that endocrine testing should be performed on all cases of laminitis that do not have a clear inflammatory or gastrointestinal origin.

Citing Articles

Effectiveness of acupuncture for equine laminitis: Systematic review and meta-analysis.

Fikri F, Purnomo A, Maslamama S, Purnama M Vet World. 2025; 18(1):60-66.

PMID: 40041523 PMC: 11873381. DOI: 10.14202/vetworld.2025.60-66.


Nutraceutical Supplement Mitigates Insulin Resistance in Horses with a History of Insulin Dysregulation During a Challenge with a High-Starch Diet.

Loos C, Castelein A, Vanzant E, Adam E, McLeod K Animals (Basel). 2024; 14(23).

PMID: 39682351 PMC: 11640219. DOI: 10.3390/ani14233385.


Sodium-glucose transport protein 2 inhibitor use in the management of insulin dysregulation in ponies and horses.

Menzies-Gow N, Knowles E J Vet Pharmacol Ther. 2024; 48 Suppl 1():31-40.

PMID: 38984777 PMC: 11736997. DOI: 10.1111/jvp.13470.


Systemic absorption of triamcinolone acetonide is increased from intrasynovial versus extrasynovial sites and induces hyperglycemia, hyperinsulinemia, and suppression of the hypothalamic-pituitary-adrenal axis.

Hallowell K, Dembek K, Horne C, Knych H, Messenger K, Schnabel L Front Vet Sci. 2024; 11:1388470.

PMID: 38828366 PMC: 11141165. DOI: 10.3389/fvets.2024.1388470.


Confidence does not mediate a relationship between owner experience and likelihood of using weight management approaches for native ponies.

Ward A, Harris P, Argo C, Watson C, Burns N, Neacsu M PLoS One. 2023; 18(10):e0292886.

PMID: 37824555 PMC: 10569591. DOI: 10.1371/journal.pone.0292886.